KLRK1 and acute myeloid leukemia: This study indicates that NKG2D+TIGIT− Vδ1 T cells are strongly correlated with improved prognosis in AML, and future research should investigate their potential in adoptive immunotherapy to advance more personalized and precise treatment strategies.